Dorsey Wright & Associates

Position in DBVT — DBV Technologies S.A.

CIK 1376772 PASADENA, CA

Position in DBVT

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,199,086

-$943,183 QoQ

Shares Held

73,115

-28.7% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#31

of 78 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Dorsey Wright & Associates holds $27,470,218 across 5 Biotechnology names. DBVT ranks #5 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	391,662	$13,860,918
2	ARWR	Arrowhead Pharmaceuticals, Inc.	97,466	$7,944,453
3	ASND	Ascendis Pharma A/S	8,427	$2,247,649
4	ABVX	Abivax S.A.	16,645	$2,218,112
5	DBVT	DBV Technologies S.A. This page	73,115	$1,199,086

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,199,086	73,115	-28.7%	Shares	Sole	2026-08-06
2026-03-31	$2,142,269	102,550	—	Shares	Sole	2026-05-06
No filing history on record for this holder in this stock.